These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12029632)

  • 1. Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periods.
    Morimoto M; Sugimori K; Shirato K; Kokawa A; Tomita N; Saito T; Tanaka N; Nozawa A; Hara M; Sekihara H; Shimada H; Imada T; Tanaka K
    Hepatology; 2002 Jun; 35(6):1467-75. PubMed ID: 12029632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation using contrast-enhanced harmonic gray scale sonography after radio frequency ablation of small hepatocellular carcinoma: sonographic-histopathologic correlation.
    Morimoto M; Nozawa A; Numata K; Shirato K; Sugimori K; Kokawa A; Tomita N; Saitou T; Nakatani Y; Imada T; Tanaka K
    J Ultrasound Med; 2005 Mar; 24(3):273-83. PubMed ID: 15723840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.
    Lu DS; Yu NC; Raman SS; Limanond P; Lassman C; Murray K; Tong MJ; Amado RG; Busuttil RW
    Radiology; 2005 Mar; 234(3):954-60. PubMed ID: 15681691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation.
    Goldberg SN; Gazelle GS; Compton CC; Mueller PR; Tanabe KK
    Cancer; 2000 Jun; 88(11):2452-63. PubMed ID: 10861420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
    Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
    Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma--CT examination during the follow-up period].
    Sugimori K; Numata K; Morimoto M; Hirao M; Hirasawa K; Oka H; Kokawa A; Shirato K; Saito T; Tanaka K; Imada T; Nozawa A
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1733-6. PubMed ID: 15553698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.
    Mikami S; Tateishi R; Akahane M; Asaoka Y; Kondo Y; Goto T; Shiina S; Yoshida H; Koike K
    J Vasc Interv Radiol; 2012 Oct; 23(10):1269-75. PubMed ID: 22999746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT.
    Lim HK; Choi D; Lee WJ; Kim SH; Lee SJ; Jang HJ; Lee JH; Lim JH; Choo IW
    Radiology; 2001 Nov; 221(2):447-54. PubMed ID: 11687689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
    Numata K; Fukuda H; Morimoto M; Kondo M; Nozaki A; Oshima T; Okada M; Takebayashi S; Maeda S; Tanaka K
    Eur J Radiol; 2012 Oct; 81(10):2746-53. PubMed ID: 22197088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy.
    Goldberg SN; Kamel IR; Kruskal JB; Reynolds K; Monsky WL; Stuart KE; Ahmed M; Raptopoulos V
    AJR Am J Roentgenol; 2002 Jul; 179(1):93-101. PubMed ID: 12076912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Luo W; Numata K; Morimoto M; Oshima T; Ueda M; Okada M; Takebayashi S; Zhou X; Tanaka K
    Eur J Radiol; 2010 Jul; 75(1):91-7. PubMed ID: 19361941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results.
    Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Lee JY; Paik SW; Koh KC; Lee JH
    Radiology; 2000 Nov; 217(2):558-63. PubMed ID: 11058660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma.
    Giorgio A; Tarantino L; de Stefano G; Scala V; Liorre G; Scarano F; Perrotta A; Farella N; Aloisio V; Mariniello N; Coppola C; Francica G; Ferraioli G
    AJR Am J Roentgenol; 2003 Aug; 181(2):479-84. PubMed ID: 12876030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty hepatocellular carcinoma: radiofrequency ablation--imaging findings.
    Pupulim LF; Hakimé A; Barrau V; Abdel-Rehim M; Zappa M; Vilgrain V
    Radiology; 2009 Mar; 250(3):940-8. PubMed ID: 19164699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of radiofrequency ablation of hepatocellular carcinoma in the hepatic dome with the CT-guided extrathoracic transhepatic approach.
    Kim YK; Kim CS; Lee JM; Chung GH; Chon SB
    Eur J Radiol; 2006 Oct; 60(1):100-7. PubMed ID: 16781835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologic comparison of monopolar versus no-touch multipolar radiofrequency ablation to treat hepatocellular carcinoma within Milan criteria.
    Seror O; N'Kontchou G; Van Nhieu JT; Rabahi Y; Nahon P; Laurent A; Trinchet JC; Cherqui D; Vicaut E; Beaugrand M; Sellier N
    J Vasc Interv Radiol; 2014 Apr; 25(4):599-607. PubMed ID: 24529547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression.
    Takaki H; Yamakado K; Nakatsuka A; Fuke H; Murata K; Shiraki K; Takeda K
    J Vasc Interv Radiol; 2007 Jul; 18(7):856-61. PubMed ID: 17609444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up.
    Sironi S; Livraghi T; Meloni F; De Cobelli F; Ferrero C; Del Maschio A
    AJR Am J Roentgenol; 1999 Nov; 173(5):1225-9. PubMed ID: 10541093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytologic changes in small hepatocellular carcinomas after radiofrequency ablation.
    Lin SM; Shen CH; Lin DY; Kuo SH; Lin CJ; Hsu CW; Chung HJ; Peng CY
    Acta Cytol; 2002; 46(3):490-4. PubMed ID: 12040642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma.
    Buscarini L; Buscarini E; Di Stasi M; Quaretti P; Zangrandi A
    Ultraschall Med; 1999 Apr; 20(2):47-53. PubMed ID: 10407974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.